The forecast for Italy's import of penicillins or streptomycins in dosage forms shows a steady increase from $114.63 million in 2024 to $115.05 million by 2028. The slight annual increments highlight a stable growth trajectory. In 2023, the import value stood lower than the projected figures for 2024, emphasizing a consistent upward trend over the forecasted period. Given the absence of significant percentage fluctuations, this growth is incrementally moderate with a calculated compound annual growth rate (CAGR) that remains positive over the five years.
Future trends to watch for:
- Potential impact of global supply chain disruptions on antibiotics import costs.
- Regulatory changes in the European pharmaceutical market affecting import dynamics.
- Technological advancements in alternative antibiotics that could shift demand.
- Market competition from local Italian antibiotic manufacturers.
